Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
Paulus Wohlfart(Universitätsklinikum Würzburg), Hartmut Ruetten(Boehringer Ingelheim (Germany))
Cited by 77
Related Papers
Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
|Cardiovascular Diabetology|2021|112
Antidiabetic profiling of veramycins, polyketides accessible by biosynthesis, chemical synthesis and precursor-directed modification
|Organic Chemistry Frontiers|2022|12
CCDC 2093275: Experimental Crystal Structure Determination
|The Cambridge Structural Database|2022|0
CCDC 2093273: Experimental Crystal Structure Determination
|The Cambridge Structural Database|2022|0
CCDC 2093274: Experimental Crystal Structure Determination
|The Cambridge Structural Database|2022|0